FDG PET Should Stay In New Tech APC, Reassignment Premature – Comments
This article was originally published in The Gray Sheet
FDG positron emission tomography should continue to be reimbursed under new technology APC 174 for one to two years under the hospital OPPS system, according to the National Electrical Manufacturers Association and AdvaMed
You may also be interested in...
CMS' decision to continue to pay for FDG positron emission tomography in new technology APC 714 under the hospital outpatient prospective payment system (OPPS) 2003 final rule is in line with comments submitted by the National Electrical Manufacturers Association and AdvaMed
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.